---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-012896"
form_type: "8-K"
ticker: "NTRB"
cik: "0001676047"
company_name: "NutriBand Inc."
filed_at: "2025-02-12T23:59:59+00:00"
generated_at: "2026-05-26T22:55:09.904858+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nutriband receives USPTO Notice of Allowance for Aversa abuse deterrent patent

## Summary
- Notice of Allowance received Feb 3, 2025 for patent app 18/369,241 covering Aversa abuse deterrent transdermal systems.
- US patent expected to issue after administrative processes; expands US IP protection for abuse deterrent transdermal portfolio.
- Lead product Aversa Fentanyl could become first abuse-deterrent opioid patch; potential peak US sales $80-200M per Health Advances.
- Aversa technology already protected by patents in 46 countries including US, Europe, Japan, China, Canada, Mexico, Australia.

## SEC filing metadata
- accession: 0001213900-25-012896
- form_type: 8-K
- ticker: NTRB
- cik: 0001676047
- company_name: NutriBand Inc.
- filed_at: 2025-02-12T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676047/000121390025012896/0001213900-25-012896-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676047/000121390025012896/ea0230859-8k_nutriband.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-012896
- JSON: https://secwatch.observer/filing/0001213900-25-012896.json
- Plain text: https://secwatch.observer/filing/0001213900-25-012896.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.